Sign in

CIK 0001724521

  • Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473898435
Phone
+1 510-694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$84,810
in 1 filing, $85K under 10b5-1 plans

Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Azoy Alexander −$85K Chief Accounting Officer sold 7% of stake

Reading 59 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 Lambert Nicole Director Grant or award +5,700 43,000
2026-06-11 Lambert Nicole Director Grant or award · Stock Option (Right to Buy) +16,900 16,900
2025-06-10 Lambert Nicole Director Grant or award +13,300 37,300
2025-06-10 Lambert Nicole Director Grant or award · Stock Option (Right to Buy) +38,300 38,300
2024-06-06 Lambert Nicole Director Grant or award +8,400 24,000
2024-06-06 Lambert Nicole Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2023-06-15 Lambert Nicole Director Grant or award +6,800 15,600
2023-06-15 Lambert Nicole Director Grant or award · Stock Option (Right to Buy) +19,500 19,500
2022-06-14 Lambert Nicole Director Grant or award +4,100 4,100
2022-06-14 Lambert Nicole Director Grant or award · Stock Option (Right to Buy) +16,800 16,800
2021-08-03 Lambert Nicole Director Grant or award +4,700 4,700
2021-08-03 Lambert Nicole Director Grant or award · Stock Option (Right to Buy) +21,700 21,700

Page 1 of 1 · 12 trades